Search Results

There are 6650 results for: content related to: Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  3. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  5. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  6. Catechol-O-Methyltransferase (COMT) Inhibitors in Parkinson's Disease

    Journal of the American Geriatrics Society

    Volume 48, Issue 6, June 2000, Pages: 692–698, Cheryl Waters

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.2000.tb04732.x

  7. Poster Session 2

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S425–S516,

    Version of Record online : 20 SEP 2006, DOI: 10.1002/mds.21247

  8. Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 75–80, Yoshikuni Mizuno, Ichiro Kanazawa, Sadako Kuno, Nobuo Yanagisawa, Mitsutoshi Yamamoto and Tomoyoshi Kondo

    Version of Record online : 8 NOV 2006, DOI: 10.1002/mds.21218

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  10. Poster session 2: Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S65–S114,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10350

  11. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Katherine Deane, Sybille Spieker and Carl E Clarke

    Published Online : 18 OCT 2004, DOI: 10.1002/14651858.CD004554.pub2

  12. Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Version of Record online : 21 OCT 2014, DOI: 10.1002/mds.26050

  13. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  14. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  15. Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

    Drug Development Research

    Volume 42, Issue 1, September 1997, Pages: 1–25, Jasper Dingemanse

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-2299(199709)42:1<1::AID-DDR1>3.0.CO;2-I

  16. Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque

    European Journal of Neuroscience

    Volume 37, Issue 5, March 2013, Pages: 831–838, Philippe Huot, Tom H. Johnston, Tessa Snoeren, James B. Koprich, Michael P. Hill, Susan H. Fox and Jonathan M. Brotchie

    Version of Record online : 3 JAN 2013, DOI: 10.1111/ejn.12093

  17. Poster Sessions: Clinical Science

    Movement Disorders

    Volume 21, Issue S13, January 2006, Pages: S81–S134,

    Version of Record online : 19 JAN 2006, DOI: 10.1002/mds.20871

  18. Poster session 1: A. Basic science, genetics, neuropharmacology, Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S17–S64,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10349

  19. Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets

    Movement Disorders

    Volume 12, Issue 6, November 1997, Pages: 935–945, Lance A. Smith, Ariel Gordin, Dr. Peter Jenner and C. David Marsden

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870120616

  20. Poster session 3: Tuesday, March 8, Poster numbers 384–592

    Movement Disorders

    Volume 20, Issue S10, February 2005, Pages: S114–S175,

    Version of Record online : 9 FEB 2005, DOI: 10.1002/mds.20424